Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sorrento Therapeutics Inc (NQ: SRNE ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 22, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sorrento Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 Next > Market Briefing For Tuesday, Sept. 14 September 14, 2021 Inflation and COVID are tied at the hip in this market and economic scenario. I assessed inflation as 'enduring and not transitory' all along, and where COVID comes into-play is as a 'spoiler' to... Via Talk Markets Market Briefing For Tuesday, Sept. 7 September 06, 2021 Economists are too worried about what's happening under the hood of the economic engine; when they really should realize all that's needed will be effective treatments and better vaccines to 'fuel' the... Via Talk Markets Market Briefing For Thursday, Sept. 2 September 02, 2021 Near parabolic uptrends exist for the S&P and the Nasdaq, encouraging bulls, who should know better regarding 'finalized phasing' of runs but there's no assurance of a repeat phase of similar moves... Via Talk Markets Topics Stocks Exposures US Equities Market Briefing For Wednesday, Sept. 1 September 01, 2021 Nuances and ambiguities dominate the market and even geopolitical scene at the moment. We are going to have hotter inflation than the Fed would like, but growth does matter, because we concurrently... Via Talk Markets Topics Economy Exposures Interest Rates Market Briefing For Wednesday, Aug.25 August 25, 2021 The stock market holds, pretty impressive ahead of 'virtual Jackson Hole', and it faded late in the day just as we thought likely for the late going. Via Talk Markets Market Briefing For Tuesday, Aug. 31 August 31, 2021 Moderate selling was masked in Monday's market, and it's against a clear backdrop of a stretched market, and even month-end pension sales, related to clients of Goldman Sachs raising 13B. The strength... Via Talk Markets Why Shares of Sorrento Therapeutics Jumped This Week August 26, 2021 The clinical-stage biopharmaceutical company published promising news in two separate studies. Via The Motley Fool Sorrento's mRNA COVID-19 Vaccine Shows Efficacy In Preclinical Study August 26, 2021 Sorrento Therapeutics Inc (NASDAQ: SRNE) has announced preclinical results for its mRNA-based COVID-19 vaccine against SARS-CoV-2. STI-mRNA includes a proprietary designer Spike... Via Benzinga Exposures COVID-19 Market Briefing For Thursday, Aug. 26 August 26, 2021 Underperformance by many stocks, but few that are really in trouble, is reflective of rising complacency, while technicians are frustrated at the lack of breakouts or breakdowns. That's actually fine,... Via Talk Markets Sorrento In-Licenses COVID-19 Targeted MPro Inhibitors August 24, 2021 Sorrento Therapeutics Inc (NASDAQ: SRNE) has entered into an option agreement with The Texas A&M University System for exclusive rights to highly... Via Benzinga Exposures COVID-19 Vaccine Victory August 24, 2021 Monday the US stock market moved into further robust mode fueled by official FDA approval of the Pfizer and BioNTech COVID-19 vaccines. Will the momentum last through to Thursday when the Fed's Jackson... Via Talk Markets Topics Economy Exposures COVID-19 Interest Rates Product Safety Market Briefing For Tuesday, Aug. 24 August 24, 2021 Suspended elevation of the S&P may be in-absence of any alternatives to do so, given what pretty much would be a 'snapping' of the short-term uptrend if that's broken. Via Talk Markets Topics Stocks Exposures US Equities Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks? August 23, 2021 If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the... Via Talk Markets Exposures Product Safety Market Briefing For Monday, Aug. 23 August 23, 2021 We might be near a moment of truth for the Senior Indexes, either in just a few days or postponed until after Labor Day. Via Talk Markets 12 Health Care Stocks Moving In Thursday's After-Market Session August 20, 2021 Gainers Geovax Labs (NASDAQ:GOVX) shares... Via Benzinga Market Briefing For Tuesday, Aug. 17 August 17, 2021 Momentum grows for a Fed taper. Investor risk now is no more than just a couple weeks ago. Actually a Fed movement is a plus as it suggest they're a believe in economic growth; which will be favorable... Via Talk Markets Topics Economy Exposures Interest Rates Market Briefing For Monday, Aug. 16 August 16, 2021 Too many permabears are almost delirious with negativity and still give extremely bearish outlooks, when that's not a correct read of markets. Via Talk Markets Week In Review: RemeGen Out-Licenses Rights For HER2 ADC To Seagen In $2.6 Billion Deal August 14, 2021 Yantai's RemeGen out-licensed global rights (ex-Asia) for its novel HER2-targeted ADC to Seagen in a $2.6 billion deal. Seagen, an antibody conjugate company, will pay $200 million upfront and up to... Via Talk Markets The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data August 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... Via Benzinga Exposures COVID-19 Why Dynavax, Novavax, and Sorrento Soared This Week August 13, 2021 There were different reasons behind each of these COVID-19 vaccine stocks' big gains. Via The Motley Fool Exposures COVID-19 Market Briefing For Thursday, Aug. 12 August 12, 2021 Fear and hysteria are not engineered by Washington about COVID, however it is a 'mood' to factor into everything from media to stock market projections. Via Talk Markets Dyadic Stock Jumps On Development Pact With Sorrento For Diagnostics & Therapies For Coronaviruses August 11, 2021 Dyadic International Inc (NASDAQ: DYAI) and Sorrento Therapeutics Inc (NASDAQ: SRNE) have announced a binding term sheet for a License Agreement to... Via Benzinga Market Briefing For Tuesday, Aug. 10 August 10, 2021 Most markets held gains as the total backdrop has not changed. Lots of money managers are eager to see a decline, to put more money 'in', but the market hasn't cooperated by dropping 'much'. Via Talk Markets 10 Health Care Stocks Showing Unusual Options Activity In Today's Session August 09, 2021 This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... Via Benzinga Thinking About Buying Stock In AMD, General Motors Or Sorrento Therapeutics? August 09, 2021 One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... Via Benzinga Market Briefing For Monday, Aug. 9 August 09, 2021 Ultimately energy markets will envision post-pandemic era robust economic activity resuming, even though Covid surges temporarily squelch demand. Via Talk Markets Cramer Advises Viewers On Palantir, SoFi And More August 04, 2021 On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer.... Via Benzinga Market Briefing For Wednesday, Aug. 4 August 04, 2021 'Subject to mandate' seems to be a catch-phrase these days; mandates to fly, to eat, to drink in a pub, to go to a show, and even to govern New York (of course that last one was an effort at humor,... Via Talk Markets Market Briefing For Tuesday, Aug. 3 August 03, 2021 We do see Tuesday turnaround as a rebound from Monday's just modest fade. Again our wildcard continues to be Covid; and the 'presumed' dovish Fed as relates to 'tapering'. Via Talk Markets Topics Economy Exposures Interest Rates Sorrento Therapeutics To Start Testing DAR-T Cell Therapy In Multiple Myeloma Patients August 02, 2021 The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ: SRNE) IND application for the Phase 1 clinical testing of its allogeneic anti-CD38 Dimeric Antigen... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.